Individual skill
conventional-oncology-hub-gene-research-planner
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
awesome-med-research-skills/Protocol Design/conventional-oncology-hub-gene-research-planner/SKILL.md
Source commit 686e09dfdb45d9fa1a08664f06bb93769b3c9d91
What was checked
- Matches the observed repository HEAD
- Yes
- Scanner rules are current
- Yes
- Repository scan complete
- No
- Skill scan complete
- Yes
- Observed behavior
- Instructions only
- Last checked
- Nov 9, 2026
These are observations at the recorded commit, not a guarantee of safety. Review the source before running it.
Install this skill
Choose an agent in your Stack or copy a command below. Commands fetch the pinned commit and copy only this skill directory. Existing destinations are refused. Copying a command does not install anything.
An install command is unavailable: current rules, complete repository and skill scans, an eligible behavior level and a permitted license are required.
Repository context
- Repository stars (not skill ratings)
- 2,042
- Repository last updated
- Sep 17, 2026
- License
- MIT
Observed agent integration: No specific integration evidence. Standard SKILL.md installation does not imply verified compatibility.
- bioinformatics Repository topic
- computational-biology Repository topic
- data-analysis Repository topic
- ai Repository topic
- biology Repository topic
- cancer-genomics Repository topic
- data-visualization Repository topic
- differential-expression Repository topic
- genomics Repository topic
- medical Repository topic
- design Derived category
- operations Derived category
- research Derived category
Files and excerpt
File metadata and permitted, redacted excerpts come from the recorded scan. Source links are pinned to that commit.
Browse files
SKILL.mdcore · 18,571 byteseval_report_conventional-oncology-hub-gene-research-planner_result.jsonasset · 13,279 bytesreferences/analysis-modules.mddoc · 4,206 bytesreferences/figure-deliverable-plan.mddoc · 4,072 bytesreferences/literature-retrieval-and-citation.mddoc · 5,272 bytesreferences/method-library.mddoc · 3,484 bytesreferences/study-patterns.mddoc · 4,256 bytesreferences/validation-evidence-hierarchy.mddoc · 6,578 bytesreferences/workflow-step-template.mddoc · 4,096 bytesreferences/workload-configurations.mddoc · 6,577 bytes
Read excerpt
> **Source**: [https://github.com/aipoch/medical-research-skills](https://github.com/aipoch/medical-research-skills)
# Conventional Oncology Hub-Gene Research Planner
You are an expert conventional oncology bulk-transcriptome biomedical research planner.
**Task:** Generate a **complete, structured research design** — not a literature summary,
not a tool list. A real, executable study plan with four workload options and a recommended
primary path.
This skill is for conventional tumor biomarker / hub-gene papers built around bulk expression datasets and clinically interpretable endpoints. Typical article logic includes: tumor vs normal differential expression, survival-associated candidate reduction, risk-model construction or prognostic filtering, PPI-based hub-gene prioritization, diagnostic / prognostic assessment, clinical association analysis, immune infiltration or checkpoint context, methylation or portal-based regulatory support, and optional tissue / cell validation.
---
## Input Validation